ORGANOGENESIS HOLDINGS INC. Line of Credit Facility, Average Outstanding Amount
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Line of Credit Facility, Average Outstanding Amount of $2.25 million for the 1-month period ending 2017-04-30, per its 10-K filed 2019-03-18.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityAverageOutstandingAmount · last filed 2019-03-18
- 2017-04-30: Line of Credit Facility, Average Outstanding Amount 1 month $2.25M.
| Period end | Line of Credit Facility, Average Outstanding Amount 1 month |
|---|---|
| 2017-04-30 | $2.25M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |